December #97 : HAART to Heart - by Charlotte Huff

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

Born Again

Knowing When to Stop

The Divine Miss Em

Alcohol

Cocaine & Heroin

Crystal Meth

Harm Reduction

Sex

Recovery Rooms

Touchdown

A for Africa

Earthwatch

WHO’s on First

Dying for ADAP

Milestones

Bombing Gilead

Pos & Neg

Wishful Thinking

Unwrapper’s Delight

Study Hell

Tech Talk

Briefs

Diarrhea Diary

HAART to Heart

Eradication II?

2/3

Breaks: What’s Up?

Safe Spliffs

Slumber Party

Bone Loss

Gimme Shelter

Adherence

IRSA’s Rochelle advises HIVer refugees:

Editor's Letter

Mailbox

Sale of a Lifetime



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

December 2003

HAART to Heart

by Charlotte Huff

Cardio concern tops docs’ risk list

Three-quarters of docs think that HIVers face increased heart-disease risk, finds an August survey by the International Association of Physicians in AIDS Care (IAPAC). Nearly half (43 percent) of the 143 doctors said they would first recommend lifestyle changes (exercise, diet, no smoking) to HIVers with questionable heart health. Others would prescribe lipid-lowering meds (27 percent) or switch HIV drugs (5 percent). One in four didn’t report recommending any intervention.

St. Louis’ Judith Aberg, MD, who reviewed the results, says that doctors shouldn’t necessarily let heart worries influence which HIV meds they initially prescribe. Studies haven’t yet determined whether elevated lipids and other heart risks result from HIV, the meds, lifestyle, genetics or just plain aging. Indeed, Aberg says, “I’m going to treat the HIV first. If, then, a patient develops risk factors for heart disease, I’ll deal with those.” But Daniel Skiest, MD, a Dallas HIV specialist, says, “For a while now, I’ve been hesitant to use protease inhibitors up front with my patients. We have plenty of drugs to start a patient on that don’t cause lipid abnormalities.”

Meanwhile, lifestyle changes can help. Of the 431 HIVers also surveyed by IAPAC, 52 percent smoked—twice the national average—but just 49 percent reported concern of cardio risk. Skiest says patients ask more about diarrhea, nausea and body shape changes than heart disease.




[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    Drew949
    South Orange County
    California


    oceanblue65
    louisiana
    Louisiana


    max38man
    Chicago
    Illinois


    daino1972
    Columbus
    Ohio
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.